Greenwich LifeSciences Files 8-K on Shareholder Vote Matters
Ticker: GLSI · Form: 8-K · Filed: Dec 18, 2025 · CIK: 1799788
| Field | Detail |
|---|---|
| Company | Greenwich Lifesciences, Inc. (GLSI) |
| Form Type | 8-K |
| Filed Date | Dec 18, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: GLSI
TL;DR
GLSI filed an 8-K about a shareholder vote. Details TBD.
AI Summary
Greenwich LifeSciences, Inc. filed an 8-K on December 18, 2025, reporting on a submission of matters to a vote of security holders. The filing does not contain specific details about the vote itself or any associated financial figures.
Why It Matters
This filing indicates that Greenwich LifeSciences is engaging with its shareholders on important corporate decisions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new material financial or operational risks.
Key Players & Entities
- Greenwich LifeSciences, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Stafford, TX (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but does not specify what those matters were.
When was the vote scheduled to take place or when did it occur?
The filing was made on December 18, 2025, and reports on the submission of matters to a vote, but does not specify the date of the vote itself.
Were there any specific proposals or resolutions presented to shareholders?
The filing indicates a submission of matters to a vote, but does not detail the specific proposals or resolutions.
What is the company's ticker symbol?
The filing does not explicitly state the ticker symbol, but the company name is Greenwich LifeSciences, Inc.
What is the company's primary business?
Greenwich LifeSciences, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Stats: 587 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-12-18 16:30:41
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value GLSI The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 43KB
- 0001493152-25-028361.txt ( ) — 207KB
- glsi-20251218.xsd (EX-101.SCH) — 3KB
- glsi-20251218_lab.xml (EX-101.LAB) — 33KB
- glsi-20251218_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Greenwich LifeSciences, Inc. Date: December 18, 2025 By: /s/ Snehal Patel Snehal Patel Chief Executive Officer -3-